EPIMMUNE INC.
17Patents
6Active
17Granted
40Portfolio score
Filing activity: Nov 29, 1993 → Dec 22, 2015 · 5 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6037135A | Methods for making HLA binding peptides and their uses | Human Necessities | 120 | Expired |
| US6534482B1 | Expression vectors for stimulating an immune response and methods of using the same | Emerging Cross-Sectional Technologies | 60 | Expired |
| US6602510B1 | HLA class I A2 tumor associated antigen peptides and vaccine compositions | Human Necessities | 56 | Expired |
| US6419931B1 | Compositions and methods for eliciting CTL immunity | Chemistry; Metallurgy | 39 | Expired |
| US6689363B1 | Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions | Chemistry; Metallurgy | 37 | Expired |
| US6413935B1 | Induction of immune response against desired determinants | Chemistry; Metallurgy | 32 | Expired |
| US7026443B1 | Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions | Chemistry; Metallurgy | 32 | Expired |
| US6322789A | HLA-restricted hepatitis B virus CTL epitopes | Chemistry; Metallurgy | 22 | Expired |
| US6464980B1 | MAGE-1 c-terminal immunogenic peptides | Human Necessities | 14 | Expired |
| US9340577B2 | HLA binding motifs and peptides and their uses | Chemistry; Metallurgy | 13 | Active |
| US6413517B1 | Identification of broadly reactive DR restricted epitopes | Emerging Cross-Sectional Technologies | 12 | Expired |
| US7888472B2 | Optimized multi-epitope constructs and uses thereof | Chemistry; Metallurgy | 9 | Active |
| US9266930B1 | Inducing cellular immune responses to Plasmodium falciparum using peptide and nucleic acid compositions | Emerging Cross-Sectional Technologies | 3 | Expired |
| US9249187B2 | Pan-DR binding polypeptides and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US8017745B2 | Plasmodium falciparum antigens and methods of use | Emerging Cross-Sectional Technologies | 1 | Active |
| US9789181B2 | PAN-DR binding polypeptides and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9511134B2 | Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.